Results 171 to 180 of about 83,573 (199)
Some of the next articles are maybe not open access.
Dexmedetomidine for Acute Management of Intrathecal Baclofen Withdrawal.
Journal of Emergency Medicine, 2019BACKGROUND Intrathecal baclofen (ITB) is a mainstay of treatment for patients with chronic spasticity. Up to 40% of all patients receiving ITB experience overdose or withdrawal symptoms, which in the most severe cases can lead to multisystem organ ...
Adam L. Gottula +3 more
semanticscholar +1 more source
Intrathecal baclofen as a treatment for spasticity: Review of the cases treated in our hospital
Neurocirugía (English Edition), 2019Introduction Spasticity represents a medical problem whose incidence is increasing during the last years due to pathologies such as cerebral palsy , stroke, multiple sclerosis , trauma or encephalopathy, affecting both adults and children. The treatments
J. M. Santín-Amo +7 more
semanticscholar +1 more source
Intrathecal baclofen for multiple sclerosis related spasticity: A twenty year experience.
Multiple Sclerosis and Related Disorders, 2019OBJECTIVE Evaluate long-term efficacy and safety of ITB in treating MS-related spasticity over ∼ 20 years of service provision in a single centre. METHODS A single centre prospective observational cohort study was performed. Eligible subjects underwent
Y. Sammaraiee +5 more
semanticscholar +1 more source
Characterization of standard work tools for intrathecal baclofen therapy
Child's Nervous System, 2021Ajay Patel +11 more
semanticscholar +1 more source
Efficacy, Indications, and Safety of Intrathecal Baclofen Pump: A Narrative Review
Current Pain and Headache ReportsA. Kaye +12 more
semanticscholar +1 more source
Effects of intrathecal baclofen therapy in subjects with disorders of consciousness: a reappraisal
Journal of neural transmission, 2020R. Nardone +7 more
semanticscholar +1 more source

